NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults1d ago
GlaxoSmithKline Pharmaceuticals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
GlaxoSmithKline Pharmaceuticals Limited held an earnings conference call for Q2 FY27, with the Managing Director and Chief Financial Officer discussing the company's performance and priorities. The company reported a strong double-digit growth in the market, with GSK delivering momentum in line with the previous quarter. Key highlights included volume growth, a good blend of price, new introductions, and volumes, and growth evenly keeled on the chronic and acute sides. The company's share of multinationals has been steadily increasing due to innovative assets contributing to the market.
BSECompany Update▲ PositiveResults1d ago
GlaxoSmithKline Pharmaceuticals Ltd
As per attachment
GlaxoSmithKline Pharmaceuticals Ltd announced its Q2 FY27 earnings conference call results, with the company's Managing Director, Bhushan Akshikar, and Chief Financial Officer, Ronojit Biswas, presenting the results. The company reported a strong double-digit growth in the market, with GSK continuing its momentum for this quarter in line with Q1. The highlights of the performance include a blend of price, new introductions, and volumes, with growths evenly keeled on both chronic and acute sides. The share of multinationals has steadily been inching upwards, thanks to innovative assets contributing to many of the multinationals, including GSK.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults1d ago
Sahajanand Medical Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Sahajanand Medical Technologies Limited has informed the Exchange about Transcript of Earnings Call for Q2 & H1FY27 Financial Results held on Thursday, November 05, 2026. The company's financial performance for Q2 and the first half of FY 2027 was a record quarter with the highest-ever revenue, EBITDA, and PAT. Revenue grew 24.7% to around INR373 crores, EBITDA grew 36.6% to INR65 crores, and PAT grew 26.6% to INR26 crores. For the half year, revenue grew 24.9% to INR725 crores, and EBITDA grew 43.4% to INR114 crores.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2d ago
Laxmi Dental Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Laxmi Dental Limited has informed the Exchange about the transcript of the Q2FY27 and H1FY27 Earnings Conference Call, held on November 04, 2026, where the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026, were discussed. The results and presentations are uploaded on the stock exchange and company website.
BSECompany Update▲ PositiveResults2d ago
Laxmi Dental Ltd
Earnings Call Transcript Q2 and H1 FY27
Laxmi Dental Ltd announced its Q2 FY27 and H1 FY27 earnings conference call transcript, with revenue at INR79.5 crores, a 38.5% growth in EBITDA, and a 17.6% growth in PAT. The company's EBITDA and PAT margins improved to 19.2% and 12.6% respectively. The growth was broad-based across the company's core dental segments.
BSECompany Update▲ PositiveResults2d ago
Power and Instrumentation (Gujarat) Ltd
Investor Presentation
Power and Instrumentation (Gujarat) Ltd has released an investor presentation for Q2FY27 and H1FY27, highlighting its business profile, scale, and backward integration through Peaton Electrical. The company has a 44.28% YoY growth in revenue, 17.25% YoY growth in EBITDA, and a 20,000+ km of HT/LT lines electrified. It has also expanded into the 400 kV EHV segment and has a 60% stake in subsidiary PECL.
NSEInvestor Presentation▲ PositiveResults2d ago
Veegaland Developers Limited
Investor Presentation
Veegaland Developers Limited has submitted an investor presentation for the unaudited financial results of the company for the quarter and half year ended September 30, 2026, showing strong growth across every key metric, with revenue from operations increasing by 28.66% YoY, EBITDA* growing by 77.76% YoY, and PAT increasing by 92.34% YoY.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2d ago
Om Power Transmission Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Om Power Transmission Limited held an earnings conference call to discuss its unaudited financial results for Q2 and H1 FY27. The company reported a 56% growth in revenue from operations for Q2FY26 and a 46% growth for the first half. The business environment remains healthy, with a strong transmission and distribution capex cycle in Gujarat and across the country. The company received several new orders, including underground cabling orders from PGVCL, GETCO, and UGVCL, and has a pipeline of additional orders.
BSEResult▲ PositiveResults2d ago
Ecofinity Atomix Ltd
Financials results for quarter and half year ended on 30th September 2026
Ecofinity Atomix Ltd has announced its unaudited financial results for the second quarter and half year ended on September 30, 2026. The company's revenue from operations was ₹2,102.01 lakhs, with a total income of ₹2,163.05 lakhs. Expenses were ₹2,082.20 lakhs, resulting in a profit before exceptional items and tax of ₹80.85 lakhs. The company's earnings per equity share (EPS) for continuing operations was ₹0.91.
BSECompany Update▲ PositiveResults2d ago
Diamond Power Infrastructure Ltd-$
Transcript of Earnings Call held on November 4, 2026
Diamond Power Infrastructure Ltd reported its Q2 FY27 and H1 FY27 earnings, with revenue from operations for Q2 at INR1,032 crores, up 135% over the same quarter last year, and EBITDA including other income at INR133 crores, up 189%.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2d ago
Diamond Power Infrastructure Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Diamond Power Infrastructure Limited has informed the Exchange about the transcript of the Earnings Call held on November 4, 2026, discussing the Company's unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 FY2027).
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2d ago
Wonderla Holidays Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Wonderla Holidays Limited has informed the Exchange about its Q2 and H1 FY27 Earnings Conference Call. The company's income grew 42% year-on-year to INR126 crores, and EBITDA grew 90% to INR30 crores. The EBITDA margin expanded to 24% from 18%. The company's existing parks, Bengaluru and Kochi, delivered their best ever Q2, and Hyderabad delivered its best ever H1. The resorts business delivered its best ever Q2, with a 57% year-on-year growth.
BSECompany Update▲ PositiveResults2d ago
Wonderla Holidays Ltd
Earnings call transcript
Wonderla Holidays Ltd reported Q2 and H1 FY27 earnings, with income growing 42% YoY to INR126 crores and EBITDA growing 90% to INR30 crores. The EBITDA margin expanded to 24% from 18%. The company attributed the performance to the continued ramp-up of Chennai operations, steady growth across existing parks, and strong quarter from its resorts business.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2d ago
Varroc Engineering Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Varroc Engineering Limited has informed the Exchange about the transcript of investor/conference call pertaining to unaudited financial results for the quarter and half year ended on September 30, 2026. The company reported strong year-on-year growth across all major automotive segments, with revenue reaching INR29,479 million, representing a growth of 33.6% year-on-year and 11.9% sequentially. The company's EBITDA margin improved to 8.9% compared with 8.5% in quarter one of FY 2027 and 9.1% in quarter two of FY 2026.
BSECompany Update▲ PositiveResults2d ago
Varroc Engineering Ltd
Transcript
Varroc Engineering Ltd reported strong growth in Q2 FY 2027 with revenue reaching INR29,479 million, a 33.6% year-on-year increase. The company's India operations grew by 29.5% year-on-year, while its overseas operations grew by 104.1%. EBITDA margin improved to 8.9% compared to 8.5% in Q1 FY 2027 and 9.1% in Q2 FY 2026.
NSEPress Release▲ PositiveResults2d ago
Mukka Proteins Limited
Press Release
Mukka Proteins Limited reports strong Q2 FY27 performance with 108.06% YoY growth in revenue, 157.51% YoY growth in PAT, and improved EBITDA margin. The company has also commenced commercial production at its Oman facility, secured U.S. FDA facility registration, and received USDA NOP inputs attestation for its Eco Sphere Organic Fertilizer product.
BSECompany Update▲ PositiveResults2d ago
Blue Dart Express Ltd
As per attachment
Blue Dart Express Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The results show a total revenue from operations of ₹1,77,393 crore and a net profit for the period of ₹13,509 crore. The earnings per share (EPS) is ₹42.98.
BSECompany Update▲ PositiveResults2d ago
Mukka Proteins Ltd
Intimation of Press Release.
Mukka Proteins Ltd reported strong Q2 FY27 performance with 108.06% YoY revenue growth, 157.51% YoY PAT growth, and improved EBITDA margin. The company's Oman facility commenced commercial production, and it received USDA NOP inputs attestation for Eco Sphere Organic Fertilizer. CARE Ratings revised the outlook to Stable from Negative.
BSECompany Update▲ PositiveResults2d ago
Aztec Fluids & Machinery Ltd
Press Release-Financial Highlights of the Unaudited Standalone and Consolidated Financial Results for the Half Year ended September 30, 2026.
Aztec Fluids & Machinery Ltd reported a 10.1% revenue growth in H1 FY27, driven by strong cash generation and a conservative balance sheet. The company's margins were impacted by elevated input costs due to the West Asia conflict, currency fluctuations, and inflation. Despite this, Aztec Fluids & Machinery Ltd maintained a robust operating cash flow and a healthy balance sheet, with a debt-to-equity ratio of 0.29x and an interest cover of 9.3x.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2d ago
Krsnaa Diagnostics Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Krsnaa Diagnostics Limited has announced its Q2 & H1 FY27 Earnings Conference Call, with the company crossing INR500 crores in revenue for the first time. The company achieved a 27% year-on-year growth, with a potential 37% growth had certain contracts continued. The management team discussed the key operating and financial highlights for the quarter and half year ended September 30, 2026.